检索

期
标题
作者
卷 16, 编号 1 (2024)
Nephrogenic anemia in patients receiving renal replacement therapy, pathogenesis and resistance
Ryasnyansky V., Shostka G., Anikonova L.
PDF
(Rus)
编号 6 (2011)
Cardiomyopathy in anemia, associated with chronic kidney disease: role of erythropoetin-beta
Fomin V., Kozlovskaya L., Milovanov Y.
编号 3 (2018)
Experience of treatment of renal anemia in patients on hemodialysis using epoetin alfa (Eralfon). Evaluation of the efficacy of therapy and comparison with foreign practice
Shutov E., Kotenko O., Pushkina A., Lashutin S., Elembaeva P.
PDF
(Rus)
编号 2 (2011)
EPIDEMIOLOGY AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC RENAL FAILIRE AND ANEMIA, RECEIVING PROGRAMM HEMODYALISISPart 2. Quality of life and costs of erythropoietin treatment
Vorob'ev P., Bezmel'nitsyna L.
编号 2 (2016)
Modern strategy for erythropoiesis-stimulating therapy in chronic kidney disease
Vetchinnikova O.
PDF
(Rus)
编号 1 (2011)
EPIDEMIOLOGY AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC RENAL FAILIRE AND ANEMIA, RECEIVING PROGRAMM HEMODYALISISPart 1. Epidemiology and use of erythropoietin medications
Vorob'ev P., Bezmel'nitsyna L.
编号 1 (2015)
Relationship of renal excretory function impairment to serum erythropoietin level in chronic heart failure
Makarova N., Zaharov J.
PDF
(Rus)
编号 2 (2011)
The efficacy and safety evaluation of the domestic erythropoietin-β. The review and open multicenter study report
Zemchenkov A., Vishnevskiy K., Gerasimchuk R., Gavrik S., Kostyleva T., Suchkov V.
编号 1 (2013)
Use of continuous erythropoietin receptor activator in treatment of anemia in patients with predialysis chronic kidney disease
Milovanova L., Milovanov Y., Kozlovskaya L.
PDF
(Rus)
编号 2 (2010)
Comparison of distribution of erythropoietin medications isoforms with two-dimensional gel-electrophoresis
Shnaider A.
编号 1 (2012)
FIRST MONOGRAPH OF E.M. TAREEV
编号 3 (2009)
Primenenie preparatov eritropoetina u bol'nykh terminal'noy pochechnoy nedostatochnost'yu, nakhodyashchikhsya na programmnom gemodialize (rezul'taty mul'titsentrovogo observatsionnogo issledovaniya)
Khasabov N., Hasabov N.
编号 2 (2012)
EXPERIENCE OF DARBEPORETIN ALFA USE IN MANAGEMENT OF ANAEMIA IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY
Novosel'tsev I., Novosel'tseva N., Kuznetsova E., Mikhaylova Y., Novoseltsev I., Novoseltseva N., Kuznetsova E., Mihailova Y., Novoseltsev I., Novoseltseva N., Kuznetsova E., Mihailova Y.
编号 1 (2009)
Citoprotective effects of erythropoietin
Zakharov Y.
编号 2 (2012)
Recombinant human erythropoietin: original preparations and biological analogues
Ermolenko V., Filatova N., Mikhaylova N., Khasabov N., Ermolenko V., Filatova N., Mikhailova N., Khasabov N.
1 - 15 的 15 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##